MPCCEL reports nine-month net loss of US$122,730

November 11, 2022

 

Total expenses for the period under review amounted to US$122,730 (2021: US$156,073). The breakdown for total expenses is as follows:

  • Accountancy fees remained at US$6,600 year over year.
  • Administrative fees declined 13% to US$41,172 (2021: US$47,118).
  • Administrative compensation fell 67% to US$12,030 (2021: US$36,364).
  • Advertising fees grew 80% to US$ 22,127 (2021: US$12,260).
  • Audit fees fell 85% to US$875 (2021: US$5,875).
  • Bank charges grew 38% to US$2,851 (2021: US$2,059).
  • Director’s fees remained at US$13,875 year over year.
  • Legal & professional fees fell 66% to US$6,174 (2021: US$$17,972).
  • License fees remained at US$375 year over year.
  • Corporate fees remained at US$1,125 year over year
  • Insurance expenses rose 25% to US$15,526 (2021: US$12,450).

Total loss for the period was reduced 21% to US$122,730 (2021: US$156,073). However, for the quarter, total loss grew 14% to US$40,335 (2021: US$35,244).

Consequently, loss per share (LPS) as at September 30, 2022 amounted to US$0.006 (2021: LPS of US$0.007). For the quarter, it remained at US$0.002. The trailing twelve-month EPS amounted US$0.054. The number of shares used in this calculation was 21,666,542 shares. MPCCEL and MPCCELUS price closed the trading period at a price of J$84 and US$0.65 on November 10, 2022 respectively.

Balance Sheet at a Glance:

Total Assets for the period grew 4% to US$30.79 million (2021: US$29.64 million). This upward movement is due to ‘Investment – MPC Caribbean Clean Energy Fund LLC’ which closed at US$30.57 million (2021: US$29.23 million).

Shareholder’s equity totalled US$20.69 million (2021: US$19.51 million). This resulted in a book value per share of USD$0.95 (2021: US$0.99).

 

Disclaimer:

Analyst Certification – The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation(s) or view (s) expressed by that research analyst in this research report.

Company Disclosure – The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may effect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.

2022-11-11T10:47:03-05:00